Literature DB >> 26678452

Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells.

Yusuke Sato1, Hiroto Hatakeyama1, Mamoru Hyodo1, Hideyoshi Harashima1.   

Abstract

While a variety of short interfering RNA (siRNA) delivery compounds have been developed, a deep understanding of the key parameters that determine the quality of siRNA delivery are not known with certainty. Therefore, an understanding of the factors required for the efficient, selective, and safe delivery of siRNA is a great challenge for successful siRNA delivery. Herein, we report on the development of two pH-sensitive cationic lipids and their use in examining the impact of the acid dissociation constant (pKa) value, lipase sensitivity and the size of lipid nanoparticles on the biodistribution, and efficiency and cell specificity of gene silencing in the liver. An increase in the pKa value resulted in a significant change in the intrahepatic localization of siRNA and gene-silencing efficiency in hepatocytes and liver sinusoidal endothelial cells (LSECs). The sensitivity of the pH-sensitive cationic lipid to lipases was a major factor in achieving hepatocyte-specific gene silencing. Increasing the particle size can improve the LSEC specificity of gene silencing. As a consequence, we succeeded in developing both a highly efficient, hepatocyte-specific formulation, and the most efficacious LSEC-targeted formulation reported to date. These findings will facilitate the development of more sophisticated siRNA delivery systems.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26678452      PMCID: PMC4886930          DOI: 10.1038/mt.2015.222

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  32 in total

1.  An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA.

Authors:  Roger C Adami; Shaguna Seth; Pierrot Harvie; Rachel Johns; Renata Fam; Kathy Fosnaugh; Tianying Zhu; Ken Farber; Michael McCutcheon; Thomas T Goodman; Yan Liu; Yan Chen; Erin Kwang; Michael V Templin; Greg Severson; Tod Brown; Narendra Vaish; Feng Chen; Patrick Charmley; Barry Polisky; Michael E Houston
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

2.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 3.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

4.  In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.

Authors:  James E Dahlman; Carmen Barnes; Omar Khan; Aude Thiriot; Siddharth Jhunjunwala; Taylor E Shaw; Yiping Xing; Hendrik B Sager; Gaurav Sahay; Lauren Speciner; Andrew Bader; Roman L Bogorad; Hao Yin; Tim Racie; Yizhou Dong; Shan Jiang; Danielle Seedorf; Apeksha Dave; Kamaljeet S Sandu; Matthew J Webber; Tatiana Novobrantseva; Vera M Ruda; Abigail K R Lytton-Jean; Christopher G Levins; Brian Kalish; Dayna K Mudge; Mario Perez; Ludmila Abezgauz; Partha Dutta; Lynelle Smith; Klaus Charisse; Mark W Kieran; Kevin Fitzgerald; Matthias Nahrendorf; Dganit Danino; Rubin M Tuder; Ulrich H von Andrian; Akin Akinc; Avi Schroeder; Dipak Panigrahy; Victor Kotelianski; Robert Langer; Daniel G Anderson
Journal:  Nat Nanotechnol       Date:  2014-05-11       Impact factor: 39.213

5.  Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors.

Authors:  Krista B Goodman; Michael J Bury; Mui Cheung; Maria A Cichy-Knight; Sarah E Dowdell; Allison K Dunn; Dennis Lee; Jeffrey A Lieby; Michael L Moore; Daryl A Scherzer; Deyou Sha; Dominic P Suarez; Dennis J Murphy; Mark R Harpel; Eric S Manas; Dean E McNulty; Roland S Annan; Rosalie E Matico; Benjamin K Schwartz; John J Trill; Thomas D Sweitzer; Da-Yuan Wang; Paul M Keller; John A Krawiec; Michael C Jaye
Journal:  Bioorg Med Chem Lett       Date:  2008-11-14       Impact factor: 2.823

6.  A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.

Authors:  Yusuke Sato; Hiroto Hatakeyama; Yu Sakurai; Mamoru Hyodo; Hidetaka Akita; Hideyoshi Harashima
Journal:  J Control Release       Date:  2012-09-20       Impact factor: 9.776

7.  Endogenously produced endothelial lipase enhances binding and cellular processing of plasma lipoproteins via heparan sulfate proteoglycan-mediated pathway.

Authors:  Ilia V Fuki; Nadine Blanchard; Weijun Jin; Dawn H L Marchadier; John S Millar; Jane M Glick; Daniel J Rader
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

Review 8.  Lipid polymorphism and the functional roles of lipids in biological membranes.

Authors:  P R Cullis; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1979-12-20

9.  Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.

Authors:  Ursula Andréo; Patrick Maillard; Olga Kalinina; Marine Walic; Eliane Meurs; Michèle Martinot; Patrick Marcellin; Agata Budkowska
Journal:  Cell Microbiol       Date:  2007-05-21       Impact factor: 3.715

10.  In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.

Authors:  Tsunamasa Watanabe; Hiroto Hatakeyama; Chiho Matsuda-Yasui; Yusuke Sato; Masayuki Sudoh; Asako Takagi; Yuichi Hirata; Takahiro Ohtsuki; Masaaki Arai; Kazuaki Inoue; Hideyoshi Harashima; Michinori Kohara
Journal:  Sci Rep       Date:  2014-04-23       Impact factor: 4.379

View more
  10 in total

Review 1.  Genetic pharmacology: progresses in siRNA delivery and therapeutic applications.

Authors:  D Scherman; A Rousseau; P Bigey; V Escriou
Journal:  Gene Ther       Date:  2017-01-25       Impact factor: 5.250

Review 2.  The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA.

Authors:  Pratikkumar Patel; Nurudeen Mohammed Ibrahim; Kun Cheng
Journal:  Trends Pharmacol Sci       Date:  2021-04-16       Impact factor: 17.638

Review 3.  Lipid nanoparticle technology for therapeutic gene regulation in the liver.

Authors:  Dominik Witzigmann; Jayesh A Kulkarni; Jerry Leung; Sam Chen; Pieter R Cullis; Roy van der Meel
Journal:  Adv Drug Deliv Rev       Date:  2020-07-02       Impact factor: 15.470

4.  Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting.

Authors:  Nour Shobaki; Yusuke Sato; Hideyoshi Harashima
Journal:  Int J Nanomedicine       Date:  2018-12-10

Review 5.  Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases.

Authors:  Naomi Benne; Daniëlle Ter Braake; Arie Jan Stoppelenburg; Femke Broere
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

6.  mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy.

Authors:  Kosuke Sasaki; Yusuke Sato; Kento Okuda; Kazuki Iwakawa; Hideyoshi Harashima
Journal:  Pharmaceutics       Date:  2022-07-28       Impact factor: 6.525

Review 7.  The Endothelium as a Driver of Liver Fibrosis and Regeneration.

Authors:  Erica Lafoz; Maria Ruart; Aina Anton; Anna Oncins; Virginia Hernández-Gea
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

8.  Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics.

Authors:  Carla B Roces; Gustavo Lou; Nikita Jain; Suraj Abraham; Anitha Thomas; Gavin W Halbert; Yvonne Perrie
Journal:  Pharmaceutics       Date:  2020-11-15       Impact factor: 6.321

Review 9.  Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.

Authors:  Yuma Yamada; Yusuke Sato; Takashi Nakamura; Hideyoshi Harashima
Journal:  J Control Release       Date:  2020-09-08       Impact factor: 9.776

Review 10.  Endothelial dysfunction in pathological processes of chronic liver disease during aging.

Authors:  Ying Wan; Xuedong Li; Elise Slevin; Kelly Harrison; Tian Li; Yudian Zhang; James E Klaunig; Chaodong Wu; Ashok K Shetty; X Charlie Dong; Fanyin Meng
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.